User profiles for W M Clark
 | William C. ClarkResearch Professor, Harvard Kennedy School of Government Verified email at hks.harvard.edu Cited by 26684 |
[BOOK][B] The determination of hydrogen ions: an elementary treatise on the hydrogen electrode, indicator and supplementary methods with an indexed bibliography on …
WM Clark - 1922 - books.google.com
… the paper The Colorimetric Determination of Hydrogen Ion Concentration and Its Applications
in Bacteriology published in the Journal of Bacteriology under the joint authorship of Clark …
in Bacteriology published in the Journal of Bacteriology under the joint authorship of Clark …
Normal interpediculate distances (minimum and maximum) in children and adults
VC HINCK, WM CLARK JR… - American Journal of …, 1966 - Am Roentgen Ray Soc
In this article refined maximum and minimum interpediculate distances are published for
use in diagnosis of intraspinal tumor and detection of spinal canal stenosis. The subject of …
use in diagnosis of intraspinal tumor and detection of spinal canal stenosis. The subject of …
Sustainability science
RW Kates, WC Clark, R Corell, JM Hall, CC Jaeger… - Science, 2001 - science.org
Meeting fundamental human needs while preserving the life-support systems of planet Earth
is the essence of sustainable development, an idea that emerged in the early 1980s from …
is the essence of sustainable development, an idea that emerged in the early 1980s from …
[HTML][HTML] Stenting versus endarterectomy for treatment of carotid-artery stenosis
…, G Howard, GS Roubin, WM Clark… - … England Journal of …, 2010 - Mass Medical Soc
Background Carotid-artery stenting and carotid endarterectomy are both options for treating
carotid-artery stenosis, an important cause of stroke. Methods We randomly assigned …
carotid-artery stenosis, an important cause of stroke. Methods We randomly assigned …
Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial
…, C Kase, M Pessin, A Ahuja, F Callahan, WM Clark… - Jama, 1999 - jamanetwork.com
ContextIntravenous tissue-type plasminogen activator can be beneficial to some patients
when given within 3 hours of stroke onset, but many patients present later after stroke onset …
when given within 3 hours of stroke onset, but many patients present later after stroke onset …
Fractures of the atlas vertebra
…, DE Duff, S Martinez, MD Miller, WM Clark - Skeletal Radiology, 1976 - Springer
In a series of 400 patients with fractures and dislocations of the cervical spine, 5% involved
the atlas. There are nearly equal numbers of fractures of the posterior arch, bursting fractures …
the atlas. There are nearly equal numbers of fractures of the posterior arch, bursting fractures …
[HTML][HTML] Endovascular therapy after intravenous t-PA versus t-PA alone for stroke
…, BM Demaerschalk, R Budzik, WM Clark… - … England Journal of …, 2013 - Mass Medical Soc
Background Endovascular therapy is increasingly used after the administration of intravenous
tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic …
tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic …
Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: a randomized controlled trial
WM Clark, S Wissman, GW Albers, JH Jhamandas… - Jama, 1999 - jamanetwork.com
ContextRecombinant tissue-type plasminogen activator (rt-PA) improves outcomes for
patients with acute ischemic stroke, but current approved use is limited to within 3 hours of …
patients with acute ischemic stroke, but current approved use is limited to within 3 hours of …
Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study
GW Albers, VE Bates, WM Clark, R Bell, P Verro… - Jama, 2000 - jamanetwork.com
ContextTissue-type plasminogen activator (tPA) is the only therapy for acute ischemic stroke
approved by the Food and Drug Administration.ObjectiveTo assess the safety profile and to …
approved by the Food and Drug Administration.ObjectiveTo assess the safety profile and to …
[HTML][HTML] Long-term results of stenting versus endarterectomy for carotid-artery stenosis
…, MD Hill, VA Mantese, WM Clark… - … England Journal of …, 2016 - Mass Medical Soc
Background In the Carotid Revascularization Endarterectomy versus Stenting Trial, we found
no significant difference between the stenting group and the endarterectomy group with …
no significant difference between the stenting group and the endarterectomy group with …
